Dory Anderson
Outliving CancerEpisodes
Episodes of Outliving Cancer
Mark All
Search Episodes...
Dr. Nagourney offers a fundamental discussion of the concept of human metabolism on today’s episode of Outliving Cancer.
Today on Outliving Cancer, Dr. Nagourney discusses the metabolic basis of human malignancy -- the history, present and future -- and new groundbreaking studies.
Today on Outliving Cancer, Dr. Nagourney introduces colleague and research collaborator Dr. Paulo D’Amora on using quantitative Mass Spectrometry in identifying metabolic signatures to determine a predisposition to disease.
Dr. Nagourney discusses on today’s episode a recent study he and colleagues conducted that was able to identify gynecologic cancer patients at the highest risk of relapse. The results could herald a future in which oncologists could use a blood
Today Dr. Robert Nagourney discusses treatment options for Triple Negative Breast Cancer, which accounts for 10 to 15 percent of all breast cancers and tends to grow and spread faster than other breast cancers.
Dr. Robert Nagourney today discusses an important presentation conducted at an American Association for Cancer Research Special Conference on Pancreatic Cancer.
Today Dr. Nagourney discusses the management of breast cancer, specifically HER2-positive breast cancer, and visits with a patient who has a remarkable story and shares her experience.
Dr. Nagourney discusses this week the issues that doctors can face when trying to help patients as they come against sometimes strict and rigid dictates in process protocols that are not always in the patient’s best interest.
Dr. Nagourney looks back in time at cancer research and then looks ahead at the potentials of treatment. He reviews the process of cell death in cancer and the potential of predictive outcomes in cancer therapy.
Dr. Nagourney reviews cancer and asks the question: What are we dealing with in cancer, and how to confront it as if going to war. Why do patients who don’t get cured become progressively more resistant to therapy?
Pancreatic cancer is one of the most challenging of all cancers. Early diagnosis for pancreatic cancer is difficult, and as a result, most people are diagnosed with later stage pancreatic cancer, which has very low survival rates. Today, howeve
Today on Outliving Cancer, Dr. Nagourney Dr. Nagourney discusses the topic of targeted therapy, the concepts, how it’s practiced, and the approach in cancer medicine.
In the previous episode, Dr. Nagourney discussed targeted cancer therapy. One particular class of targeted agents are called epidermal growth factors. The epidermal growth factor receptor protein is involved in cell signaling pathways that cont
Dr. Nagourney today discusses how cancer is a clonal disease, and how that impacts potential treatm
Vitamin C truly may be an excellent option for fighting cancer. It is increasingly evident that Vitamin C, known for its antioxidant properties, can also function as a “pro-oxidant”. Pro-oxidants introduce higher levels of toxic free radicals i
Dr. Nagourney turns detective today as he deciphers and ultimately exposes the herbal treatment PC-SPES for prostate cancer as non-herbal. But he has not given up that some herbal agents may be helpful in cancer treatment and prevention.
Dr. Nagourney today examines the options for bladder cancer and the potential for a new class of drugs.
Dr. Nagourney discusses the development of drug resistance in colon cancer patients that contributed to the failure of the oxaliplatin-based HIPEC PRODIGE 7 Trial
Dr Nagourney looks at the amazing impact foods such as garlic can have on cancer. Garlic contains more than a dozen active chemical substances, many of which have been shown to have antiviral, antibacterial, blood pressure and cholesterol lower
Dr. Nagourney discusses treatment of pancreatic cancer and options while interviewing a patient with cancer of the pancreas.
Today Dr. Nagourney examines this year’s American Society of Clinical Oncology annual meeting and some significant breakthroughs in immunotherapy.
In the study of human metabolism, Dr Nagourney today discusses the metabolic abnormalities that lead to breast cancer.
In 2021, we will have 1.9 million new diagnosis of cancer and 600,000 deaths in the U.S. alone. Today Dr. Nagourney will be discussing how cancer comes from alterations in metabolism.
Dr. Nagourney today discusses that just because a cancer drug works, it does not answer why it works.
Dr. Nagourney discusses how, in January of 1985, while a fellow at Scripps Clinic in La Jolla, California, he conducted the original laboratory experiments that tested 2-CdA against hairy cell leukemia, showing for the first time that this drug
Join Podchaser to...
- Rate podcasts and episodes
- Follow podcasts and creators
- Create podcast and episode lists
- & much more
Unlock more with Podchaser Pro
- Audience Insights
- Contact Information
- Demographics
- Charts
- Sponsor History
- and More!
- Account
- Register
- Log In
- Find Friends
- Resources
- Help Center
- Blog
- API
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More
- © 2024 Podchaser, Inc.
- Privacy Policy
- Terms of Service
- Contact Us